$5.45
-0.02[-0.37%]
At close: Apr 25
$5.45
0[0.00%]
After Hours: 4:20PM EDT
Monte Rosa Therapeutics
(NASDAQ:GLUE)Monte Rosa Therapeutics Stock (NASDAQ:GLUE), Quotes and News Summary
Monte Rosa Therapeutics Stock (NASDAQ: GLUE) stock price, news, charts, stock research, profile.
| Open | $5.350 |
| Close | $5.450 |
| Volume / Avg. | 134.428K / 132.659K |
| Day Range | 5.110 - 5.520 |
| 52 Wk Range | 2.440 - 8.840 |
| Market Cap | $273.340M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 37 |
| Short Interest | 6.25% |
| Days to Cover | 9.35 |
Recent News
No news found
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Monte Rosa Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Monte Rosa Therapeutics (GLUE) stock?
You can purchase shares of Monte Rosa Therapeutics (NASDAQ: GLUE) through any online brokerage.
Who are Monte Rosa Therapeutics's (GLUE) competitors?
Other companies in Monte Rosa Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Inozyme Pharma (NASDAQ:INZY), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP) and Tevogen Bio Holdings (NASDAQ:TVGN).
What is the target price for Monte Rosa Therapeutics (GLUE) stock?
The latest price target for Monte Rosa Therapeutics (NASDAQ: GLUE) was reported by Wedbush on Thursday, February 15, 2024. The analyst firm set a price target for 11.00 expecting GLUE to rise to within 12 months (a possible 101.83% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Monte Rosa Therapeutics (GLUE)?
The stock price for Monte Rosa Therapeutics (NASDAQ: GLUE) is $5.45 last updated April 25, 2024 at 4:20 PM EDT.
Does Monte Rosa Therapeutics (GLUE) pay a dividend?
There are no upcoming dividends for Monte Rosa Therapeutics.
When is Monte Rosa Therapeutics (NASDAQ:GLUE) reporting earnings?
Monte Rosa Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
Is Monte Rosa Therapeutics (GLUE) going to split?
There is no upcoming split for Monte Rosa Therapeutics.
What sector and industry does Monte Rosa Therapeutics (GLUE) operate in?
Monte Rosa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.